← Back to Analyst Consensus 
ALXO Buy
ALX ONCOLOGY HOLDINGS INC
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 19, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Mar 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 5, 2026 | Piper Sandler | maintain | Overweight → Overweight | $4 | 54% |
| May 21, 2025 | UBS | maintain | Buy → Buy | $1 | 54% |
| May 9, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $2 | 44% |
| Mar 7, 2025 | Stifel | maintain | Hold → Hold | $1.5 | 53% |
| Mar 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 6, 2025 | Piper Sandler | maintain | Overweight → Overweight | $9 | 54% |
| Mar 6, 2025 | Jefferies | upgrade | Hold → Buy | $3 | 52% |
| Jan 27, 2025 | UBS | maintain | Buy → Buy | $2.2 | 54% |
| Jan 24, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Jan 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Dec 19, 2024 | Jefferies | downgrade | Buy → Hold | $2 | 52% |
| Dec 18, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Dec 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Nov 12, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 16, 2024 | UBS | maintain | Buy → Buy | $4 | 54% |
| Aug 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Aug 12, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 9, 2024 | Stifel | reiterate | Hold → Hold | $3 | 53% |
| Aug 1, 2024 | Stifel | maintain | Hold → Hold | $5 | 53% |
| Aug 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Jun 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| May 29, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Apr 12, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Apr 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Mar 8, 2024 | Piper Sandler | maintain | Overweight → Overweight | $21 | 54% |
| Mar 8, 2024 | Stifel | downgrade | Buy → Hold | $14 | 53% |
| Dec 8, 2023 | Jefferies | upgrade | Hold → Buy | $18 | 52% |
| Nov 14, 2023 | Stifel | maintain | Buy → Buy | $10 | 53% |
| Oct 11, 2023 | Piper Sandler | maintain | Overweight → Overweight | $11 | 54% |
| Oct 4, 2023 | UBS | maintain | Buy → Buy | $27 | 54% |
| Oct 4, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $23 | 50% |
| Oct 3, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| Sep 12, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $18 | 50% |
| Aug 14, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $18 | 50% |
| Aug 11, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $18 | 50% |
| Aug 11, 2023 | Piper Sandler | maintain | Overweight → Overweight | $8 | 54% |
| Aug 11, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Jul 24, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $22 | 50% |
| May 12, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Mar 15, 2023 | UBS | maintain | — → Buy | $29 | 54% |
| Mar 10, 2023 | Credit Suisse | maintain | — → Outperform | $34 | — |
| Mar 10, 2023 | HC Wainwright & Co. | maintain | — → Buy | $30 | 44% |
| Nov 9, 2022 | HC Wainwright & Co. | maintain | — → Buy | $65 | 44% |
| Aug 9, 2022 | Credit Suisse | maintain | — → Outperform | $38 | — |
| Jun 6, 2022 | Stifel | maintain | — → Buy | $16 | 53% |
| May 19, 2022 | Piper Sandler | maintain | — → Overweight | $48 | 54% |
| Mar 1, 2022 | Stifel | maintain | — → Buy | $36 | 53% |
Price Target Trend
Apr 13, 2026 Latest: $4.6 Oct 24, 2026
EPS Estimates
0q $-0.13
Lo: $-0.16 Hi: $-0.10
6 analysts ▲4
+1y $-0.55
Lo: $-0.74 Hi: $-0.40
6 analysts ▲3
+1q $-0.13
Lo: $-0.17 Hi: $-0.09
6 analysts ▲4
0y $-2.64
Lo: $-3.58 Hi: $-1.70
2 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days